1-3 of 3
David C. Dorn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CDK4/6 Inhibitor PD 0332991 Sensitizes Acute Myeloid Leukemia to Cytarabine-Mediated Cytotoxicity

Chenyi Yang, Cynthia A. Boyson, Maurizio Di Liberto, Xiangao Huang, Jeffrey Hannah, David C. Dorn, Malcolm A.S. Moore, Selina Chen-Kiang, Pengbo Zhou
Journal: Cancer Research
Cancer Res (2015) 75 (9): 1838–1845.
https://doi.org/10.1158/0008-5472.CAN-14-2486
Published: 30 April 2015
View articletitled, CDK4/6 Inhibitor PD 0332991 Sensitizes Acute Myeloid Leukemia to Cytarabine-Mediated Cytotoxicity
Open the PDF for CDK4/6 Inhibitor PD 0332991 Sensitizes Acute Myeloid Leukemia to Cytarabine-Mediated Cytotoxicity in another window
Includes: Supplementary data
Journal Articles

The Migrastatins: A new family of metastatasis inhibitors

David C. Dorn, Jon T. Njardarson, Mihirbaran Mandal, Christoph Gaul, Cynthia Kou, Kang Zhang, Vladimir Ponomarev, Samuel L. Danishefsky, Malcolm A. S. Moore
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1207–1208.
Published: 01 May 2005
View articletitled, The Migrastatins: A new family of metastatasis inhibitors
Journal Articles

Fludelone, an optimized epothilone for ovarian cancer treatment

David C. Dorn, Yuong Shin Cho, Daniel Procissi, Michaela Liedtke, Kang Zhang, Vladimir Ponomarey, Jason A. Koutcher, Samuel J. Danishefsky, Malcolm A. S. Moore
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1390.
Published: 01 May 2005
View articletitled, Fludelone, an optimized epothilone for ovarian cancer treatment